Motus GI Reports First Quarter 2024 Financial Results and Provides Corporate Update
Motus GI Appoints Experienced Financial Biotech Executive, Sonja Nelson, to its Board of Directors and as Chair of Audit Committee
Read ReleaseMotus GI Announces First Patients Enrolled in the European Union Feasibility Study of the Pure-Vu® System as a New Method for Bowel Cleansing in Patients With a History of Poor Bowel Preparation
Read ReleaseMotus GI Announces Publication of Pure-Vu® System Clinical Data in Peer-Reviewed Journal BMC Gastroenterology
Read ReleaseMotus GI Announces Publication of a Pure-Vu System® Cost Effectiveness Analysis in the Journal of Cost Effectiveness and Resource Allocation
Read ReleaseMotus GI Submits 510(k) Application to FDA for the Pure-Vu System for Upper GI Endoscopy
Read Release